Fanconi syndrome leading to hypophosphatemic osteomalacia related to tenofovir use

2Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

Abstract

Tenofovir disoproxil fumarate (TDF) is used worldwide to treat and prevent Human Immunodeficiency Virus (HIV) infection. Fanconi syndrome is a complication of TDF use and is characterized by inadequate reabsorption of glucose, phosphate and protein in the proximal tubule of the kidney which may eventually lead to osteomalacia manifested by symptoms of pain, muscular weakness and difficulty ambulating. We present a patient with severe osteomalacia due to progressive and unrecognized Fanconi’s syndrome, who responded rapidly to TDF withdrawal, oral phosphate repletion and calcitriol. With the widespread use of TDF-containing antiviral regimens, it is critically important that physicians adhere to screening recommendations to detect early Fanconi syndrome, and recognize symptoms of osteomalacia as a serious complication.

Cite

CITATION STYLE

APA

Rao, M., Dadey, L., Glowa, T., & Veldkamp, P. (2021). Fanconi syndrome leading to hypophosphatemic osteomalacia related to tenofovir use. Infectious Disease Reports, 13(2), 448–453. https://doi.org/10.3390/IDR13020044

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free